Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeoLacta Lifesciences is a biotechnology company specializing in the development and manufacture of human milk-based nutritional products for premature and critically ill infants. As the first company in Asia to establish a pharmaceutical-grade facility for processing human milk, NeoLacta provides a range of products including human milk fortifiers, pasteurized human breast milk, and human milk-derived cream. Their mission is to improve clinical outcomes in neonatal intensive care units (NICUs) by providing 100% human milk-based diets, which help reduce the incidence of complications like necrotizing enterocolitis. The company utilizes advanced processing technologies to ensure the safety and nutritional integrity of their products while supporting the unique needs of fragile neonates. Headquartered in Bengaluru, India, NeoLacta works closely with healthcare professionals to standardize human milk nutrition in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeoLacta Lifesciences.